2709045-56-5
Chemical Structure
AKT-IN-10
- CAS No.: 2709045-56-5
- Formula:C26H34ClN5O2
- Molecular Weight:484.03
IUPAC Name: (2S)-2-(4-chlorophenyl)-1-(3-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)-3-(isopropylamino)propan-1-one
InChIKey: MCBUZAMSHFCOIL-KPDOXARCSA-N
SMILES: C[C@H]1C2=C(N3CC4CCC(N4C([C@@H](C5=CC=C(C=C5)Cl)CNC(C)C)=O)C3)N=CN=C2[C@@H](C1)O
Biological Activity: AKT-IN-10 is a potent inhibitor of AKT. Protein kinase B (PKB, also known as AKT) is central to PI3K/AKT/mTOR signaling in cells, and its function is important for cell growth, survival, differentiation and metabolism. AKT-IN-10 has the potential for the research of breast and prostate cancer (extracted from patent WO2021185238A1, compound 4)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AKT-IN-10 | AKT-IN-10 is a potent inhibitor of AKT. Protein kinase B (PKB, also known as AKT) is central to PI3K/AKT/mTOR signaling in cells, and its function is important for cell growth, survival, differentiation and metabolism. AKT-IN-10 has the potential for the research of breast and prostate cancer (extracted from patent WO2021185238A1, compound 4). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
